The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
BRCA1 like copy number profiles to predict benefit of intensified alkylating chemotherapy in breast cancer.
Philip C. Schouten
No relevant relationships to disclose
Sabine C. Linn
Consultant or Advisory Role - Named inventor on a patent application for the BRCA1-like test (U)
Sebastian Aulmann
No relevant relationships to disclose
Hans-Peter Sinn
No relevant relationships to disclose
Andreas Schneeweiss
No relevant relationships to disclose
Frederik Marme
No relevant relationships to disclose